According to the immunostaining evaluation, in general, OLC1 lowly (Figure 1A), moderately (Figure 1B) and highly (Figure 1C) expressed in 48(13.7%), 180(51.6%) and 121(34.7%) of the total 349 gastric adenocarcinoma patients respectively. The gene discussed is IST1; the disease is gastric adenocarcinoma.